Human Vaccines & Immunotherapeutics·YesterdayOptimizing pneumococcal prevention in South African older adults: Cost-effectiveness of PCV20 versus PPSV23 in the context of HIV-associated riskComputational studyInterventionsPaper
The Lancet Public Health·7 SepGlobal, regional, and national prevalence of second-hand smoke and attributable disease burden in 204 countries and territories, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023Computational studyPopulationsPaper
International Journal of Rheumatic Diseases·12 AugImmunosuppressant Use Mediates Neuroprotection Against Alzheimer's Disease in Rheumatoid Arthritis-A Two-Step Mendelian Randomization and NHANES StudyMendelian randomisation in 217 peopleRheumatoid arthritisPaper
Diabetes Research and Clinical Practice·8 AugData-source choice in diabetes mortality surveillance and equity monitoring in the United States, 1999-2023Computational studyPopulationsPaper